DTC Audiences

DTC Audiences | Case Studies

Swoop Swoop

Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%

A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.

DTC Audiences | Case Studies

Swoop Swoop

Activating Patients on Addressable TV Generates 1,500 New-to-Brand Starts for Type 2 Diabetes Drug

A pharmaceutical brand wanted to increase reach, doctor’s visits and drive prescription lift of its Type 2 diabetes drug nationally. Swoop built a privacy-safe segment of patients on the brand and its competitors. Targeted ads on linear addressable devices scaled across MVPDs, maximizing frequency to saturate the North American market.

DTC Audiences | Case Studies

Swoop Swoop

Precision over Quantity: How Swoop, CMI Media Group, and Genentech Unlocked Qualified Patient Reach on Meta

While Genentech’s social campaigns were driving significant website traffic, the time spent on site by patients wasn’t meeting their engagement goals. The CMI Media Group team, in partnership with Swoop, recognized an opportunity to refine their targeting strategy to reach a more qualified audience. By leveraging Swoop’s expertise in healthcare audience insights, the team aimed […]

DTC Audiences | Case Studies

Swoop Swoop

Targeting De-identified Hepatitis Patients via Addressable TV Increases Prescriptions 24%

A leading pharmaceutical brand wanted to further optimize targeting on addressable TV by testing and comparing Swoop’s audience segments against its current vendor. Swoop generated a privacy-safe segment of currently diagnosed patients based on real world health data against the provider’s universe for six weeks, running twice weekly.

DTC Audiences | Product Overviews

Swoop Swoop

Swoop DTC Audiences Overview

Reach 99% of your DTC target with Swoop’s 100% compliant audiences across all 50 states.